Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Ductal carcinoma in situ

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Perspektiver på recidiverende respiratorisk papillomatose og humant papillomvirus-vaccination

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Balanced translocation in a patient with abortus habitualis and normal karyotype

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Gentagne diploid biparental molae

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Lukning af forreste tredjedel af sinus sagittalis superior hos en patient med to blyanter i hjernen

    Research output: Contribution to journalJournal articleCommunication

  5. Fatal kakeksi ved mitokondriel neurogastrointestinal encefalomyopati.

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Pattern of mortality after menopausal hormone therapy: long-term follow up in a population-based cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Nonaspirin NSAIDs and contralateral breast cancer risk

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Tidlig opsporing og behandling af brystkræft

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Low-dose aspirin use and risk of contralateral breast cancer: a Danish nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Reply to: Adequate use of radioactive seed localisation. Where we are?

    Research output: Contribution to journalComment/debateResearch

View graph of relations

Ductal carcinoma in situ (DCIS) is a premalignant lesion in the breast. It is often asymptomatic and diagnosed by screening mammography. DCIS is treated in line with low-risk invasive breast cancer including mastectomy or breast-conserving treatment plus radiotherapy, implicating a risk of both physical and psychological side effects. Since only a part of DCIS lesions develop into invasive cancer, some women suffer from overtreatment. However, it remains yet to be identified, in which subgroup of women with DCIS treatment can safely be omitted. We need to know more about the natural course of DCIS and develop tools to tailor treatment individually.

Translated title of the contributionDuctal carcinoma in situ
Original languageDanish
JournalUgeskrift for Laeger
Volume180
Issue number38
ISSN0041-5782
Publication statusPublished - 17 Sep 2018

ID: 56652673